Share
Other content recommended for you
- Neurofilament light chain as a biomarker in neurological disorders
- Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers
- Neuropathology and emerging biomarkers in corticobasal syndrome
- Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
- Biomarkers in dementia: clinical utility and new directions
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid
- Amyloid PET imaging in clinical practice
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum